| Active Ingredient | CARBETOCIN |
| Therapeutic Class | OXYTOCICS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DINOPROSTONE |
| Therapeutic Class | OXYTOCICS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ERGOMETRINE MALEATE |
| Therapeutic Class | OXYTOCICS |
| Indications | Postpartum haemorrhage. |
| Caution |
Nausea, vomiting. Caution should be exercised in p atients with heart disease, hypertension and vascular disease. c.f. prescribing in liver and renal disease p. 13; 28. |
| Dose Range | Oral: 0.2-0.4mg every 6-12 hours. I.M. 200mcg every 2-4 hours for up to 5 doses. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OXYTOCIN |
| Therapeutic Class | OXYTOCICS |
| Indications | Induction of labour. |
| Caution | To be used for medical rather than elective induction of labour. Refrigerate. |
| Dose Range | 0.5-1mu/minute (equal to 3-6ml p er hour).the dose should be gradually increased in increments of 1-2mu/minute at 30-60 minute intervals until contraction is established. Once labour has progressed to 5-6cm dilation, the dose may be reduced by sim |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SERUMS TOXOIDS AND VACCINES |
| Therapeutic Class | SERUMS, TOXOIDS AND VACCINES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ALBUMIN |
| Therapeutic Class | SERUMS |
| Indications | Plasma volume replacement, restoration of colloid osmotic pressure. |
| Caution | Anaphylaxis; chills; fever; hypersensitivity reactions . |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ANTI D IMMUNOGLBULIN |
| Therapeutic Class | SERUMS |
| Indications | Prevention of D (RhO) sensitisation in RhD negative women |
| Caution | Risk of sensitization |
| Dose Range | Routine antenatal prophylaxis: 2 doses of 500 units given at weeks 28 and 34 gestation. Postnatal prophylaxis is still necessary. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ANTI-D IMMUNOGLOBULIN |
| Therapeutic Class | SERUMS |
| Indications | Prevention of D (RhO) sensitisation in RhD negative women. |
| Caution | Risk of sensitization. |
| Dose Range |
Routine antenatal prophylaxis: 2 doses of 500 units given at weeks 28 and 34 gestation. Postnatal prophylaxis is still necessary. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IMMUNOGLOBULIN HUMAN |
| Therapeutic Class | SERUMS |
| Indications | Passive Immunity. |
| Caution | Hypersensitivity . |
| Dose Range | IV, IM , or SC according to Indications: |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TETANUS ANTITOXIN |
| Therapeutic Class | SERUMS |
| Indications | Passive Immunity. |
| Caution | As for Immunoglobulin. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIPHTHERIA TOXOID | HAEMOPHILUS B |
| Therapeutic Class | TOXOIDS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIPHTHERIA TOXOID | TETANUS TOXOID |
| Therapeutic Class | TOXOIDS |
| Indications | Active Immunization |
| Caution | Mild local reaction consisting of pain, erythema, tenderness and induration at injection site are common and may be associated with systemic reactions including mild to moderate transient More ... |
| Dose Range | Inject 0.5 mL intramuscularly |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TETANUS TOXOID |
| Therapeutic Class | TOXOIDS |
| Indications | Active Immunisation. |
| Caution | Local reaction. Fever, headache, and malaise may start a few hours after injection and last for 1 or 2 days. |
| Dose Range | According to schedule. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIPHTHERIA | TETANUS |
| Therapeutic Class | VACCINES |
| Indications | Active immunisation |
| Caution | Mild local reaction consisting of pain, erythema, tenderness and induration at injection site are common and may be associated with systemic reactions including mild to moderate transient More ... |
| Dose Range | - 0.5ml given intra-muscularly. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIPHTHERIA | TETANUS | PERTUSIS |
| Therapeutic Class | VACCINES |
| Indications | Active Immunisation |
| Caution | Mild local reaction consisting of pain, erythema, tenderness and induration at injection site are common and may be associated with systemic reactions including mild to moderate transient More ... |
| Dose Range | - 0.5ml given intra-muscularly. |
| Drug Interactions | Febrile illness.Diarrhoea. (OPV should be postponed).Convulsion within 1-48 hours following pertussis - omit pertussis at next visit. |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | HAEMOPHILUS B DIPTHERIA |
| Therapeutic Class | VACCINES |
| Indications | Active Immunisation. |
| Caution | Local reaction, fever,malaise. |
| Dose Range | Inject 0.5ml IM. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PNEUMOCOCCAL |
| Therapeutic Class | VACCINES |
| Indications | Active immunization. |
| Caution | Local reaction, fever, malaise. |
| Dose Range | According to schedule. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | POLIOMYELITIS |
| Therapeutic Class | VACCINES |
| Indications | Active immunization. |
| Caution | Local reaction, fever, malaise. |
| Dose Range | According to schedule. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SALMONELLA TYPHI |
| Therapeutic Class | VACCINES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | STREPTOCOCCUS PNEUMONIA TYPES |
| Therapeutic Class | VACCINES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |